MedPath

Prevention of Noise-induced Damage by Use of Antioxidants

Not Applicable
Conditions
Noise-induced Hearing Loss
Noise-induced Tinnitus
Interventions
Drug: Antioxidantia
Registration Number
NCT01727492
Lead Sponsor
University Hospital, Antwerp
Brief Summary

The current study is a dubble-blinde placebo-controlled cross-over study verifying the preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein which should be taken 1h before leisure noise above 100dB for at least 30 minutes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age: 18-25 years old
  • Temporary tinnitus after noise exposure: loudness >5 on a VAS
Exclusion Criteria
  • middle ear problems
  • Allergy for magnesium or n-acetylcystein
  • Use of hearing protection when going out

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
AntioxidantiaAntioxidantiaDosage: 600mg n-acetylcystein and 200mg magnesium intake: 1 hour before leisure noise exposure above 100dB of at least 30 minutes frequency: 4 separate events (2x placebo, 2x antioxidants)
Primary Outcome Measures
NameTimeMethod
Protection against noise-induced tinnitus due to antioxidants

Antioxidants protect against temporary threshold shift. The most prevalent cause of noise-induced tinnitus is noise-induced hearing loss. Therefore, it is assumed that the preventive intake of antioxidants prior to a loud event, might protect against threshold shift as well as noise-induced tinnitus.

A 50% decrease of tinnitus loudness scored on a Visual Analogue Scale (VAS) compared to placebo trials is expected.

Secondary Outcome Measures
NameTimeMethod
Change of tinnitus duration

It is expected that with the intake of antioxidants noise-induced tinnitus is prevented or reduced after loud music exposure. In addition, it is expected that the tinnitus persistence is shortened compared to the placebo arm.

Trial Locations

Locations (1)

Antwerp University Hospital

🇧🇪

Antwerp, Edegem, Belgium

© Copyright 2025. All Rights Reserved by MedPath